Sign Up to like & get
recommendations!
0
Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2018.07.023
Abstract: BACKGROUND We assessed 2 investigational 11- and 12-valent vaccines, containing capsular polysaccharides of 10 serotypes as in the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) and CRM197-conjugated capsular polysaccharides of serotypes 19A (11-valent) or…
read more here.
Keywords:
phid;
pneumococcal non;
booster;
non ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Urologia internationalis"
DOI: 10.1159/000517891
Abstract: BACKGROUND Beyond prostate-specific antigen (PSA), other biomarkers for prostate cancer (PCa) detection are available and need to be evaluated for clinical routine. OBJECTIVE The aim of the study was to evaluate the Prostate Health Index…
read more here.
Keywords:
prostate;
comparison phi;
phid;
cohort ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Pediatrics"
DOI: 10.1542/peds.2016-3148
Abstract: Tocilizumab profoundly improved the inflammatory features of PHID and thus may be beneficial for PHID-associated autoinflammation. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) is associated with recessive mutations in SLC29A3, encoding the equilibrative nucleoside…
read more here.
Keywords:
autoinflammation;
phid syndrome;
phid;
tocilizumab treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.864111
Abstract: Background Early screening of clinically significant prostate cancer (csPCa) may offer opportunities in revolutionizing the survival benefits of this lethal disease. We sought to introduce a modified prostate health index density (mPHI) model using imaging…
read more here.
Keywords:
mphi;
prostate;
clinically significant;
detection ... See more keywords